U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07258225) titled 'Clinical Effectiveness of a Once-daily Regimen of Tigecycline Compared to the Standard Regimen' on Nov. 13.
Brief Summary: To compare the clinical response (efficacy) and the safety of the tigecycline once daily regimen versus the standard regimen (twice daily regimen). Clinical response was categorized as a cure, failure of treatment, or indeterminate outcome.24 Treatment success (Cure): defined as resolution of signs/symptoms of infection, microbiological cure (negative cultures after tigecycline use), improvement of infection markers (leukocytic count, C reactive protein, and procalcitonin).
Treatment failure: defined as persiste...